These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17379248)

  • 1. Effective treatment of experimental autoimmune neuritis with human immunoglobulin.
    Lin HH; Spies JM; Lu JL; Pollard JD
    J Neurol Sci; 2007 May; 256(1-2):61-7. PubMed ID: 17379248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of experimental autoimmune neuritis with Fc fragment of human immunoglobulin.
    Lin HH; Wang MX; Spies JM; Pollard JD
    J Neuroimmunol; 2007 May; 186(1-2):133-40. PubMed ID: 17482276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
    Taylor JM; Pollard JD
    Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin preparation attenuates neurological signs in rat experimental autoimmune neuritis with the suppression of macrophage inflammatory protein -1α expression.
    Kajii M; Kobayashi F; Kashihara J; Yuuki T; Kubo Y; Nakae T; Kamizono A; Kuzumoto Y; Kusunoki S
    J Neuroimmunol; 2014 Jan; 266(1-2):43-8. PubMed ID: 24262701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis).
    Niknami M; Wang MX; Nguyen T; Pollard JD
    J Peripher Nerv Syst; 2013 Jun; 18(2):141-52. PubMed ID: 23781961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rats with experimental allergic neuritis using high dose immunoglobulin.
    Jia J; Jia J; Pollock M
    Chin Med J (Engl); 2000 Dec; 113(12):1096-9. PubMed ID: 11776144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
    Xia RH; Yosef N; Ubogu EE
    J Neuroimmunol; 2010 Feb; 219(1-2):54-63. PubMed ID: 20034679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat.
    Enders U; Toyka KV; Hartung HP; Gold R
    J Neuroimmunol; 1997 Jun; 76(1-2):112-6. PubMed ID: 9184640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.
    Lonigro A; Devaux JJ
    Brain; 2009 Jan; 132(Pt 1):260-73. PubMed ID: 18953054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects.
    Zhang Z; Zhang ZY; Schluesener HJ
    J Immunol; 2009 Sep; 183(5):3081-91. PubMed ID: 19675162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
    Hahn AF
    Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
    Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
    Exp Neurol; 2008 Apr; 210(2):681-90. PubMed ID: 18261728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of intravenous immunoglobulin in CIDP.
    Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
    Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Ras attenuates the course of experimental autoimmune neuritis.
    Kafri M; Kloog Y; Korczyn AD; Ferdman-Aronovich R; Drory V; Katzav A; Wirguin I; Chapman J
    J Neuroimmunol; 2005 Nov; 168(1-2):46-55. PubMed ID: 16154640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve ischemia in Guillain-Barré syndrome: an alternative mechanism for early conduction failure.
    Berciano J; García A
    Rev Neurol (Paris); 2002 Mar; 158(3):364-5. PubMed ID: 11976600
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiological studies of Guillain-Barré syndrome with different susceptibilities to develop EAN serum on 2 strains of rats.
    Low PA; Schmelzer J; Dyck PJ; Kelly JJ
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():81-90. PubMed ID: 6984386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Aminopyridine ameliorates experimental autoimmune neuritis in Lewis rats.
    Moriguchi K; Miyamoto K; Kusunoki S
    J Neuroimmunol; 2017 Apr; 305():72-74. PubMed ID: 28284349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S; Sorensen PS
    J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Nennesmo I; Adem A; Zhu J
    Exp Neurol; 2004 Dec; 190(2):486-94. PubMed ID: 15530887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.